Relationship between age and blastocyst chromosomal ploidy analyzed by noninvasive preimplantation genetic testing for aneuploidies (niPGT-A).


Journal

JBRA assisted reproduction
ISSN: 1518-0557
Titre abrégé: JBRA Assist Reprod
Pays: Brazil
ID NLM: 101684552

Informations de publication

Date de publication:
06 10 2020
Historique:
pubmed: 30 7 2020
medline: 13 10 2021
entrez: 30 7 2020
Statut: epublish

Résumé

To assess the relationship between human blastocyst chromosomal ploidy established by niPGT-A and increasing age. This is a prospective multicenter study carried out by ten assisted reproduction centers after their embryologists acquired training and validated their results with the previous use of niPGT-A. A total of 94 couples with indication for niPGT-A due to increase maternal age, male factor, repeated implantation failures, recurrent abortion or because they requested niPGT-A were included in this study. The couples had no karyotype abnormalities. After ICSI, the embryos were cultured until blastocyst stage using one or two step culture systems, single or sequential media respectively, at 37°C in an atmosphere of 6-7% CO2 and 5-20% O2 incubators. On day 3, we re-evaluated cleavage embryos to complete cumulus cells removal. The embryos were then cultured in individual well, with 20µl of medium under oil until they reached blastocyst stage. The blastocysts were vitrified and stored in liquid nitrogen. After that, the spent blastocyst culture medium (20µl) was transferred to a PCR tube and sent for analysis in the genetic laboratory, where it was stored at -80°C until sequencing. A total of 243 samples of spent blastocyst culture medium were collected on the 5th/6th day. Cell-free DNA secreted on culture medium was amplified using NICS Sample Preparation Kit (Yikon Genomics), based on the MALBAC technology. After whole genome amplification, the DNA was measured using a Qubit 2.0 fluorometer and subjected to next generation sequencing (NGS) using Illumina MiSeq® platform. The data were analyzed using the ChromGo® software (Yikon Genomics). The mean age of the patients was 38±4.08 years with an interval of 20-44 years. The euploid was diagnosed in 36.4% (80/220) of cases, aneuploidy in 31.3% (69/220), and mosaicism in 32.3% (71/220; with ≥60% aneuploidy) of blastocysts. Mosaic values ranged from 29.8% to 33.8% in different age groups. Individually, the most frequent chromosomal abnormality was XXY (Klinefelter Syndrome) occurring in 18 cases, followed by chromosome 21 (trisomy/monosomy) in 8 cases. The niPGT-A data showed a ≥60% incidence of aneuploid cells in all cases of chromosomal mosaicism (n=71). A high degree of mosaicism with aneuploidy cells was detected, and some hypotheses were suggested for this data (niPGT-A sensitivity in detecting the self-correction of chromosomal abnormalities phenomenon). However, it did not vary remarkably with age. On the other hand, euploidy levels had a negative correlation with age and aneuploidy levels had a positive relationship. This is the first report in the literature to relate chromosomal ploidy in blastocysts using niPGT-A and increasing patient age.

Identifiants

pubmed: 32723707
doi: 10.5935/1518-0557.20200061
pmc: PMC7558893
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

395-399

Références

Hum Reprod. 2019 Jan 01;34(1):181-192
pubmed: 30418565
Aust N Z J Obstet Gynaecol. 2019 Apr;59(2):317-324
pubmed: 30811595
Reprod Biol Endocrinol. 2018 Jan 26;16(1):6
pubmed: 29373974
Fertil Steril. 2019 Dec;112(6):1071-1079.e7
pubmed: 31551155
Fertil Steril. 2019 Sep;112(3):510-519
pubmed: 31200971
Gynecol Endocrinol. 2016 Jun;32(6):506-8
pubmed: 26872945
Reprod Biol Endocrinol. 2016 Jun 24;14(1):35
pubmed: 27342051
Fertil Steril. 2017 Jul;108(1):62-71.e8
pubmed: 28579407
Hum Reprod Update. 2014 Jul-Aug;20(4):571-81
pubmed: 24667481
Fertil Steril. 2018 Jun;109(6):1127-1134.e1
pubmed: 29935648
Fertil Steril. 2018 Jan;109(1):77-83
pubmed: 29191449
Reprod Biol Endocrinol. 2020 May 29;18(1):57
pubmed: 32471441
Fertil Steril. 2019 Feb;111(2):280-293
pubmed: 30691630
Fertil Steril. 2017 May;107(5):1085-1091
pubmed: 28390692
Rev Reprod. 1999 Sep;4(3):125-34
pubmed: 10521149
Reprod Biomed Online. 2018 Aug;37(2):242-245
pubmed: 30075841
J Transl Med. 2019 Mar 8;17(1):73
pubmed: 30849973
Proc Natl Acad Sci U S A. 2016 Oct 18;113(42):11907-11912
pubmed: 27688762
J Assist Reprod Genet. 2017 Apr;34(4):487-493
pubmed: 28188593
Hum Reprod. 2019 Jun 4;34(6):998-1010
pubmed: 31114858
Hum Genet. 2017 Jul;136(7):805-819
pubmed: 28393271
Nat Commun. 2016 Mar 29;7:11165
pubmed: 27021558
N Engl J Med. 2015 Nov 19;373(21):2089-90
pubmed: 26581010
Mol Hum Reprod. 2018 Dec 1;24(12):593-601
pubmed: 30371814
Hum Reprod. 2018 Jul 1;33(7):1342-1354
pubmed: 29796631
Hum Reprod Update. 2020 Apr 15;26(3):313-334
pubmed: 32141501

Auteurs

Laura D Vagnini (LD)

Paulista Center for Diagnosis Research and Training Ribeirao Preto Brazil Paulista Center for Diagnosis Research and Training, Ribeirao Preto - CPDP, Brazil.

Claudia G Petersen (CG)

Paulista Center for Diagnosis Research and Training Ribeirao Preto Brazil Paulista Center for Diagnosis Research and Training, Ribeirao Preto - CPDP, Brazil.
Centre for Human Reproduction Prof Franco Jr Ribeirao Preto Brazil Centre for Human Reproduction Prof Franco Jr, Ribeirao Preto, Brazil.

Adriana Renzi (A)

Paulista Center for Diagnosis Research and Training Ribeirao Preto Brazil Paulista Center for Diagnosis Research and Training, Ribeirao Preto - CPDP, Brazil.

Felipe Dieamant (F)

Centre for Human Reproduction Prof Franco Jr Ribeirao Preto Brazil Centre for Human Reproduction Prof Franco Jr, Ribeirao Preto, Brazil.

João B A Oliveira (JBA)

Centre for Human Reproduction Prof Franco Jr Ribeirao Preto Brazil Centre for Human Reproduction Prof Franco Jr, Ribeirao Preto, Brazil.

Antonio H Oliani (AH)

São José do Rio Preto School of Medicine FAMERP Sao Jose do Rio Preto Brazil São José do Rio Preto School of Medicine FAMERP, Sao Jose do Rio Preto, Brazil.

Maria C T Canas (MCT)

Paulista Center for Diagnosis Research and Training Ribeirao Preto Brazil Paulista Center for Diagnosis Research and Training, Ribeirao Preto - CPDP, Brazil.

Raul Nakano (R)

Ferticlin Human Fertility Clinic Sao Paulo Brazil Ferticlin Human Fertility Clinic, Sao Paulo, Brazil.

Carlos G Almodin (CG)

Materbaby Maringa Brazil Materbaby, Maringa, Brazil.

Condesmar Marcondes (C)

Santista Nucleus of Human Reproduction Santos Brazil Santista Nucleus of Human Reproduction, Santos, Brazil.

Alvaro Ceschin (A)

Feliccita Fertility Institute Curitiba Brazil Feliccita Fertility Institute, Curitiba, Brazil.

Adelino Amaral (A)

Genesis Human Reproduction Assistance Center Brasília Brazil Genesis Human Reproduction Assistance Center, Brasília, Brazil.

Jonathas B Soares (JB)

Alpha Project-Alliance of Assisted Fertilization Laboratories São Paulo Brazil Alpha Project-Alliance of Assisted Fertilization Laboratories, São Paulo, Brazil.

Joaquim Lopes (J)

Cenafert Salvador Brazil Cenafert, Salvador, Brazil.

Antonio C Franco (AC)

Embryolife São José dos Campos Brazil Embryolife, São José dos Campos, Brazil.

Jose G Franco (JG)

Paulista Center for Diagnosis Research and Training Ribeirao Preto Brazil Paulista Center for Diagnosis Research and Training, Ribeirao Preto - CPDP, Brazil.
Centre for Human Reproduction Prof Franco Jr Ribeirao Preto Brazil Centre for Human Reproduction Prof Franco Jr, Ribeirao Preto, Brazil.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH